Health
Merck and Moderna Achieve Milestone with mRNA Cancer Vaccine
By Editor • August 19, 2026 • 1 min read
Merck and Moderna report success in a late-stage trial for their personalized mRNA cancer vaccine, signaling a breakthrough in cancer treatment.
Read more